Category: Pharmaceutical

Categories
Pharmaceutical

Powder-Filled Hard Gelatine Capsules Influential Factors Determining the Trajectory of the Market 2031

According to Fact.MR, Insights of Powder-Filled Hard Gelatine Capsules is a specialized and in-depth study of the industry with a special focus on the Key Trends of Powder-Filled Hard Gelatine Capsules is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

A survey offers detailed analysis on key growth drivers of Powder-Filled Hard Gelatine Capsules and trends accelerating Powder-Filled Hard Gelatine Capsules sales globally. The survey also gives detailed analysis on the competitive landscape of Powder-Filled Hard Gelatine Capsules identifying key players and analyzing the impact of their growth strategies.

Request for a Brochure– https://www.factmr.com/connectus/sample?flag=B&rep_id=5694

Key Segments of Global Powder-filled hard gelatine capsules Market Covered in the Report

·       Based on Source, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Type A Gelatine (pork skin)
    • Type B Gelatine (bovine bones)

·       Based on the Capsule size, the Global Powder-filled hard gelatine capsules Market has been segmented as

    • 000 Capsule Size
    • 00 Capsule Size
    • 0 Capsule Size
    • 1 Capsule Size
    • 3 Capsule Size

·       Based on the Dosage System, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Magnetically controlled capsule
    • Immediate-release Capsules
    • Sustained-release Capsules
    • Delayed-release Capsules

·       Based on the Application, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Antibacterial
    • Anticancer
    • Anti-inflammatory
    • Analgesics
    • Cardiovascular Drugs
    • Cough And Cold Drug
    • Antacid & Anti-flatulent Drugs
    • Antiemetic’s
    • Others

·       Based on the End Users, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Pharmaceutical Industry
    • Nutraceutical Industry
    • Cosmetic Industry
    • Research Laboratories

·       Based on the region, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • Middle East & Africa

What is the Repercussion of the Pandemic on the Growth of the Global Powder-Filled Hard Gelatine Capsules Market?

The closure has likewise prompted an end in assembling exercises across a few nations which prompted delay in development of worldwide Powder-filled hard gelatine Capsules market development. A huge interruption in store network exercises was seen in worldwide Powder-filled hard gelatine Capsules market due the exchange limitations drove on borders for import and fares of crude materials across the lines. There was a decrease in tolerant visits and treatment selection rate in the midst of Coved adversely affecting worldwide Powder-filled hard gelatine Capsules market.

 Request Customized Report as Per Your Requirements- https://www.factmr.com/connectus/sample?flag=RC&rep_id=5694

Competitive Landscape

Key players for hard gelatine Capsule are such as

  • ACG Worldwide
  • Qualicaps
  • Suheung Co. Ltd.
  • CapsCanada Corporation
  • Qingdao Yiqing Medicinal Capsules Co.Ltd.
  • Shanxi Guangsheng Medicinal Capsules Co.Ltd
  • Healthcaps India Ltd.
  • Snail Pharma Industry Co. Ltd.
  • Roxlor
  • Sunil Healthcare Ltd.
  • Medi-Caps Ltd.
  • Nectar Lifesciences Ltd.
  • Natural Capsules Ltd.
  • Bright Pharma Caps Inc.
  • and others are actively involved in offering Powder-filled hard gelatin capsules for different applications.

 Key Highlights:-

  • Sales of Powder-Filled Hard Gelatine Capsules In 2020
  • Competitive Analysis Of Powder-Filled Hard Gelatine Capsules
  • Demand Analysis Of Powder-Filled Hard Gelatine Capsules
  • Key Trends Of Supply Side Analysis Of  Powder-Filled Hard Gelatine Capsules
  • Outlook Of Powder-Filled Hard Gelatine Capsules
  • Insights Of  Powder-Filled Hard Gelatine Capsules
  • Analysis Of Powder-Filled Hard Gelatine Capsules
  • Survey Of Powder-Filled Hard Gelatine Capsules
  • Size Of Powder-Filled Hard Gelatine Capsules

A short viewpoint offered in the report elucidates the macro-economic aspects that influence the growth drivers of Powder-Filled Hard Gelatine Capsules  which includes global GDP growth rate, various industries growth rate, such as cosmetics, pharmaceuticals, food and others.

This newly published and insightful report compounds sheds light on key dynamics, Key Trends of Powder-Filled Hard Gelatine Capsules  and their impact on the overall value chain from suppliers to end-users, which are expected to transform the future of the global Powder-Filled Hard Gelatine Capsules  sales.

Why choose Fact.MR?                                         

We carry immense pride in saying that our work is recognized by 150+ countries worldwide. Our experience is conveyed by the fact that we have published 6, 000+ reports, thanks to our dedicated team of professionals. With digital intelligence solutions, we support our clients in remaining at the driver’s seat. Our crew of 300+ analysts are available 24/7 to offer dynamic updates regarding various verticals and companies.

Categories
Pharmaceutical

Increasing demand for assisted reproductive technology (ART) will Capitalize the Global Cryopreservation and Fertilization Media Market: Fact MR Study

Fact MR- A Market Research and Competitive Intelligence Provider: Manufactures in the market are producing improved version with life span ranging from six months to one year. As IVF clinics, hospitals, academic research centers are the target end-users of the cryopreservation & fertilization media market, availability of such advanced products will fuel demand, finds Fact MR in a study.

In 2017, According to the Society of Assisted Reproductive Technology, 10,936 women froze their eggs in the U.S. As compared to data analysis of 2009, the number has increased to 23%. Considering this effect, Silicon Valley superiors such as Google and Facebook offered oocyte cryopreservation services as part of benefit plan to their employees. It has created growth opportunities in the cryopreservation & fertilization media market.

The sudden pandemic has created a severe impact on the IVF sector. IVF process needs months of planning and processing. Thus, number of treatment cycles have decreased significantly will drop demand of IVF products.

Cryopreservation is process of freezing eggs, sperms, and embryos to a subzero temperature. It increases the life span of the cells. IVF fertilization media is used in-vitro fertilization process to inseminate and incubate of oocytes.

Request Free Demo of this Report

https://www.factmr.com/connectus/sample?flag=B&rep_id=5707

Key takeaways:

  • In 2018, in the U.S., 306,197 ART cycles were performed at the 456 clinics increasing demand in U.S. capitalizing the market.
  • East Asian Economies such as China and South Korea has witnessed decreased birth rates and are expected to boost the demand of new products.
  • Government in emerging economies taking initiatives that support assisted reproductive technology (ART) treatment.
  • Asian countries are promoting incentives and program funding to IVF fertilization.

Growth drivers:

  • Commercialization of the media has created competition which has increased the standards and has implemented it to the clinical practice.
  • Increased awareness about the IVF technologies further expected to boost the growth of market.

Key restraints:

  • High cost of IVF and cryopreservation may restrict market expansion.
  • Less awareness of assisted reproductive technology (ART) treatments in developing countries.

Request for customization of Cryopreservation & Fertilization Media Market Report at
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5707

Competitive landscape:

Key players in the cryopreservation & fertilization media market are aiming on product upgradation key strategy. This will help key players to gain progression in increasing market shares. For instance:

  • In February 2020, Kitazato produced enhanced version of Vitrification and thawing media. It has 3 months longer life span than previous version.
  • In October 2019, FUJIFLIM Irvine Scientific attained approval for assisted reproductive technology (ART) treatments expanding company values in the European regions.

Other key players operating in the market are Cooper Surgical, Vitrolife AB, Cook Medical, FUJIFILM Irvine scientific, Kitazato corporation, Genea Biomedx, GYNEMED GmbH & Co.,KG (A Hamilton Thorne Company), FERTIPRO NV, Nidacon International AB, Microm Ltd.

More Insights on the Global Cryopreservation and Fertilization Media Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global cryopreservation and fertilization media market presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the cryopreservation and fertilization media market with a detailed segmentation based on product type (cryopreservation media and fertilization Media) based on media type (single Step Media and sequential/Two-step media) based on end user (In-Vitro fertility centers, hospitals, and academic research institutes), based on region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East, and Africa)

Explore Fact. MR’s Coverage on the Healthcare Domain

Smart Fertility Tracker Market Report: Fact.MR gives a detailed assessment of smart fertility tracker market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Fertility Tourism Market: Fact.MR’s extensive coverage on fertility tourism market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across key geographies, along with important information concerning key manufacturers operating within the market.

Gamete Preservation Market: Fact.MR’s expansive preclinical gamete preservation market report sheds light on the prominent dynamics expected to shape future growth. The study offers insights into the key drivers, opportunities and trends prevailing across key segments. Also, information regarding leading key players has been included in the report.

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Demand for Minimally Invasive Surgeries Will Drive Surgical Imaging Robots Market: Fact MR Study

Surgical imaging robots are increasingly used during surgeries conducted for the treatment of spinal rope injury, cerebral paralysis, rheumatoid joint pain, loss of motion, accidental patients, multiple sclerosis (MS), and other condition. In the near future, the surgical imaging robots market will register higher application in response to the increasing demand for minimally invasive surgeries, finds Fact MR in a study.

According to the World Health Organization (WHO), nearly 703 people around the world were aged 65 years and older. The number is likely to increase to 1.5 billion by 2050. Aged people are considered more vulnerable to rheumatoid arthritis and bone injury. Against this backdrop, Fact MR identifies the rising geriatric population as a chief growth driver.

The market also has been gaining from recent approvals by the Food and Drug Administration (FDA). For instance, in 2019, Intuitive Surgical, Inc., received 510 (k) FDA clearance for its robotic surgical system called Ion. Coupled with this, the increasing adoption of robot-assisted surgeries will create attractive opportunities for growth in the near future.

Request Free Demo of this Report – https://www.factmr.com/connectus/sample?flag=B&rep_id=5692

Key takeaways:

  • The U.S. offers lucrative growth opportunities backed by the presence of a well-established medical infrastructure and rising healthcare expenditure.
  • The clinical automated frameworks will surpass $17 billion by 2020 fuelling global surgical imaging robot market.
  • The demand for surgical robots will continue rising due to application in various surgeries
  • Hospitals will emerge as key end user backed by higher footfall of patients.
  • Increasing application in neurosurgery and orthopedic surgeries will fuel demand in the market

Prominent drivers:

  • The rising prevalence of cardiovascular and neurological diseases and resultant demand for minimally invasive surgeries will push growth.
  • Technological advancements are underway to launch next-generation features in surgical imaging robots. These developments will create opportunities for growth in the coming years.
  • The rising number of knee and hip replacement surgeries will create scope for application of surgical imaging robots.

Key restraints:

  • Operating difficulties faced while using new imaging robotic instruments might hamper widespread uptake.
  • Fear of mechanical and human errors might restrict the use of surgical imaging robots.

Competitive Landscape:

Key players are adopting expansion strategies to increase their share in the global surgical imaging robot market. Besides this, they are focusing on new product launches. For instance:

  • In February 2020, Digital Surgery, which is a privately owned surgical AI company, was acquired by Medtronic

Key players operating in the market are Medtronic, Intuitive Surgical, GE Healthcare, Philips, Siemens and Covidien, Blue Frog Robotics, Double Robotics, Fourier Intelligence, CT Asia Robotics, F&P Robotics, Cyberdyne, and Mojin Robotics.

Get Customization on this Report for Specific Country – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5692

More Insights on the Global Surgical Imaging Robot Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global Surgical Imaging Robot Market presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the Surgical Imaging Robots market with a detailed segmentation based on product type (Surgical robots, neurological surgery robotic system, cardiology surgery robotic system, Laparoscopic surgery robotic system, Orthopaedic surgery robotic system, Gynecologic robotic surgery, Urology robotic surgery), application (Orthopedicurgery, Neurosurgery, Gynecologic Surgery, Cardiothoracic Surgery, Urology, General Surgery, Plastic Surgery), and end user (hospitals, ambulatory surgical centers, diagnostic centers, and rehabilitation center) across North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

Key Questions Covered in the Report

  • How will the surgical imaging robot market expand through 2031?
  • Which are top manufacturing companies in the global surgical imaging robot market?
  • What are the key drivers and opportunities that will stimulate the surgical imaging robot market sales?
  • What are the restraints that will affect the sales of the surgical imaging robot market?
  • Which region will remain the most lucrative throughout the forecast period?
  • What is the impact of COVID-19 on the surgical imaging robot market?

Explore Fact.MR’s Coverage on the Healthcare Domain

Non-invasive Coronary Imaging: Fact.MR gives a detailed assessment of non-invasive coronary imaging market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Holotomographic Imaging Market: Fact. MR’s extensive coverage on holotomographic imaging market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across key geographies, along with important information concerning key manufacturers operating within the market.

Preclinical Brain Imaging Market: Fact.MR’s expansive preclinical brain imaging market report sheds light on the prominent dynamics expected to shape future growth. The study offers insights into the key drivers, opportunities and trends prevailing across key segments. Also, information regarding leading key players has been included in the report.

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Strimvelis Gene Therapy will Surpass US$ 5 Bn by 2026, Exhibiting a Stellar Growth Rate

170 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of
Gene Therapy Market Over the Forecast Period 2021-2026

The Fact.MR study on the Gene Therapy market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Product, Application , and Region. The report also highlights the scope of Gene Therapy over the assessment period

Gene therapies have emerged as a promising treatment approach to address various diseases such as cancer, and certain inherited disorders with a single curative dosage. Although they are poised to ensure cost savings in the long run, their high initial expenses and uncertainties regarding their prolonged efficacy are an existing challenge for market players. The global gene therapy market revenue will surge over 3X over 2020-2026.

Government agencies including, the Food and Drug Administration (FDA), and the European Medicines Agency (EMA), have approved the usage of drug – Kymriah, and Yescarta – to treat elapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL), and diffuse large B-cell lymphoma (DLBCL). However, the market uptake of both these gene therapy products have been below par.

For detailed insights on enhancing your product footprint, request for a sample here- 
https://www.factmr.com/connectus/sample?flag=S&rep_id=4648

Despite the ongoing issues, the worldwide revenue of gene therapy market will surpass US$ 5 Bn by 2026, exhibiting a stellar growth rate. At-scale investments in the field of gene-related R&D, and increasing number of late-stage gene therapy candidates in oncology and other genetic disorders are likely to oil the growth engine.

Gene Therapy Market Segmentation

The Fact.MR study scrutinizes the global gene therapy market on the basis of product, application and key regions.

Product
  • Yescarta
  • Kymriah
  • Luxturna
  • Strimvelis
  • Gendicine
Application
  • Ophthalmology
  • Oncology
  • Adenosine Deaminase?Deficient Severe Combined Immunodeficiency (ADA-SCID)
Region
  • The US
  • Europe
  • Rest of World

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4648

Key Takeaways of the Gene Therapy Market:

  • In terms of revenue, Yescarta holds prominence in the gene therapy market, while Luxturna stays ahead in terms of annual growth rate.
  • Over half of gene therapy research studies are focused on the field of oncology, attributable to notable rise in caseloads of various cancer types.
  • The US currently represents the most lucrative opportunities in the gene therapy market; while Europe is expected outpace the region towards the end of forecast period.
  • Fast uptake of regulatory bodies in the US and Europe for approval and commercialization of gene therapy products are likely to propel market growth.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4648

“Cancer types including, DLBCL, and acute lymphoblastic leukemia (ALL) are among the major causes of mortalities across the globe, especially in developed regions. Realizing the immense potential of gene therapy in treating rare diseases, governments are investing in gene therapy treatment centers to increase access to enhanced patient pool”, Says an Analyst at Fact.MR.

Market Players to Establish Proprietary Manufacturing Units

Amidst rising pool of patients suffering from cancer, governments, biopharmaceutical companies, and research institutes are significantly driving their attention towards gene-centric R&D projects. This is setting high hopes for gene therapy market players. However, as a response to increasing costs and delays associated with pulling in third-party contract manufacturers, leading market players are establishing proprietary manufacturing plants.

For instance, Novartis AG has invested US$ 500 Mn to set up its own gene therapy manufacturing facility, following Pfizer Inc. which has allocated US$ 600 Mn for the same. Such a tactic will help manufacturers safeguard proprietary production techniques and deal with concerns issued by regulatory authorities more efficiently.

As third-party contract manufacturers house limited production capacity for upcoming gene therapy methods under development stage, internal manufacturing units in the long run is an imperative for gene therapy market players.

Looking for more information?

The research study on the gene therapy treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the gene therapy market during 2020–2026.

Market statistics have been elucidated based on product (Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine), application (Ophthalmology, Oncology, and Adenosine Deaminase-deficient Severe Combined Immunodeficiency (ADA-SCID)) and across key regions (The US, Europe and Rest of World).

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of Low Vision Devices Is Expected to Surpass a Valuation of US$ 7,170.2 Mn By the End of 2026

Technological advancements, combined with adequate research and development, has led to a significant development in assistive technologies. The introduction of electronic mobility aids like Ray and UltraCane have led to incredible developments in the assistive technologies for visually impaired market.

Driven by these technological advancements, the assistive technologies demand for visually impaired market is projected to grow impressively, registering a CAGR of 8.6% during the forecast period (2020-2026). Other drivers, such as increasing geriatric population, rising cases of visual impairment and increase in healthcare expenditure shall also augment the demand for assistive technologies for the visually impaired. On this premise, the market is expected to surpass a valuation of US$ 7,170.2 Mn by the end of 2026.

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4635

Assistive Technologies Demand for Visually Impaired Market segmentation

Fact.MR has studied the assistive technologies demand for visually impaired market with detailed segmentation on the basis product type, end-users and key regions.

Product Type
  • Educational Devices & Software:
  • Braille Duplicators & Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Mobility Devices:
  • Canes
  • Low Vision Devices:
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
End-users
  • Blind Schools
  • Enterprises & Social Organizations
  • Personal Use
  • Federation & Hospitals
  • Others
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4635

Key Takeaways of Assistive Technologies Demand for Visually Impaired Market Study

  • Product-wise, the educational devices & software segment shall constitute the maximum share of the assistive technologies demand for visually impaired market. Projections indicate a market share of around 58%. This is due to increased spending on education by public and private entities.
  • Mobility devices are expected to catch up, owing to introduction of new technologies such as Wayband, Dot Smartwatch and Be My Eyes. The segment shall expand at a CAGR of 8.8% during the forecast period.
  • Regionally, the assistive technologies demand for visually impaired market shall be dominated by North America. High adoption of technologically advanced devices and easy access by people are cited as key reasons. Projections indicate a market share of approximately 40%.
  • Asia-Pacific shall exhibit remarkable progress during the forecast period. The region shall surpass a valuation of US$ 1,649.2 Mn by the end of 2026. Increased adoption of technological devices in the educational sector such as braille translators, reading machines, magnifiers and mobility devices are considered key drivers propelling the market growth.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4635

“The assistive technologies demand for visually impaired market demonstrates prolific growth in the future. Rising adoption of computerized technology in education and mobility are expected to leverage prospects for the market,” infers a Fact.MR analyst.

assistive technologies demand for visually impaired market 01

Product Launches to Shape Assistive Technologies Demand for Visually Impaired Market Landscape

New product launches with technological advancements constitute the main strategy of key market players. Dolphin Computer Access Ltd, a British company, is set to promote its Connect & Learn, Whiteboard Wizard and EasyReader technologies at the upcoming VIEW 2020 Conference in Birmingham, Ireland. Consisting of Qualified Teacher of the Visually Impaired (QTVI) driven innovations, these platforms shall aim to provide quality education to low-vision learners. Similarly, Access Ingenuity provides technology solutions in the form of vision enhancing products like large print keyboards. These keyboards, titled ZoomText and Keys-U-See, provide large-sized alphabets to assist people with poor vision. The second invention, Victor Reader Trek, provides audio recordings of books to help readers enjoy the reading experience.

For More Insights
https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Looking for more information?

The research study on the Assistive Technologies Demand for visually impaired market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the Assistive Technologies Demand for Visually Impaired market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Educational Devices & Software, Mobility Devices, Low Vision Devices and Others) and end users (Blind Schools, Enterprises & Social Organizations, Personal Use, Federation & Hospitals and Others) across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent

Categories
Pharmaceutical

Cell-Based Flow Cytometry Is Projected to Account for Three-Fifth of the Total Market :Report Fact.MR

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

On the back of the aforementioned factors, the demand for flow cytometry is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Global Flow Cytometry Market Segmentation

Fact.MR has studied the global flow cytometry market with detailed segmentation on the basis of technology, products & services, application, end-users and key regions.

Technology
  • Cell-based
  • Bead-based
Products & Services
  • Reagents & Consumables
  • Flow Cytometry Instruments
  • Software
  • Services
Application
  • Pharmaceutical & Drug Discovery
  • Diagnostics
End-users
  • Pharmaceutical & Drug Discovery
  • Diagnostics
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Takeaways of Global Flow Cytometry Market Study

  • Cell-based flow cytometry shall dominate the flow cytometry market, projected to account for three-fifth of the total market during the forecast period. The ease of developing models of interconnected cellular pathways for scientists is a major driver behind the segment’s growth.
  • Products & Services-wise, the flow cytometry instruments shall constitute a major chunk of the flow cytometry market. Projections indicate a market share of around 40% for flow cytometry instruments between 2020 and 2025. Greater usage of advanced flow cytometry instruments in novel drug discovery is boosting the market.
  • Pharmaceutical and drug discoveries shall find maximum application of flow cytometry in the future. This is attributed to increased research and development activities by major pharmaceutical companies for therapeutic drug development. The segment is anticipated to hold a market share of around 45% during the forecast period.
  • Academic & Research Institutions are expected to find maximum usage of flow cytometry. The segment is expected to grow staggeringly at a CAGR of 11.6% during the forecast period. Increased research for novelty, efficacy, toxicity and safety of medicines are major drivers for the growth of this segment.
  • North America shall dominate the global flow cytometry market during the forecast period, accounting for more than one-third of the total flow cytometry market. Government campaigns to increase awareness about chronic diseases and increased research and development are factors augmenting the market growth in the region.
  • However, Asia-Pacific is expected to register stellar growth during the forecast period, expanding at a CAGR of 14%. A burgeoning pharmaceutical industry, development of new biologics, vaccines and drugs are expected to leverage future growth of the flow cytometry market.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4633

global flow cytometry market 1

“The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry market’s prospects in the future”, concludes a Fact.MR analyst.

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players:

  • Becton Dickinson & Company.
  • Merck & Co.Inc.
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • SYSMEX CORPORATION
  • Alere Inc.
  • Miltenyi Biotec
  • Bio-Techne
  • Agilent Technologies Inc. 
  • Bio-Rad Laboratories Inc.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4633

Looking for more information?

The research study on the global flow cytometry market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global flow cytometry market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Technology (Cell-based and Bead-based), Products & Services (Reagents & Consumables, Flow Cytometry Instruments, Software and Services), Application (Pharmaceutical & Drug Discovery, Diagnostics and Others) and End-Users (Hospitals & Diagnostic Labs, Academic & Research Institutions and Others) across five major regions.

Report Benefits & Key Questions Answered

  • Flow Cytometry Company & brand share analysis: The report offers brand-share analysis on Flow Cytometry market to offer a more in-depth competition deep-dive. This is intended at assisting companies at proactive long-term planning.
  • Flow Cytometry Historical volume analysis: Factors affecting sales in the past are analyzed in detail. The report also offers comparative analysis between growth trajectory exhibited in 2016-2020 and 2020-2025.
  • Flow Cytometry Category & segment level analysis: To offer a comprehensive analysis, the market identifies leading segments and highlights chief factors enabling growth across these categories.
  • Flow Cytometry Consumption by demographics: The demographic analysis is intended at providing recommendations to companies to help them create growth strategies around dynamic consumption patterns.
  • Flow Cytometry Manufacturing trend analysis: Manufacturing trend analysis is the key highlight of the study. It offers vital data on strategies adopted by market players to align their manufacturing strategies as per prevailing market trends.            

Get More Insights

https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent Source: https://www.factmr.com/media-release/1395/global-flow-cytometry-market

Categories
Pharmaceutical

Cost Benefits of In Vitro Fertilization Technology In Asia Pacific are Attracting Reproductive Care Seekers from Across the Globe: Fact.MR

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Assisted Reproductive Technology Market Over the Forecast Period 2020-2025

The Fact.MR study on the assisted reproductive technology market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Procedure ( Frozen Donor, Frozen Non-Donor, Fresh Donor) , End User (Fertility Clinics, Hospitals), and Technology (In Vitro Fertilization, Artificial Insemination, Surrogacy). The report also highlights the scope of assisted reproductive technology over the assessment period

In-vitro fertilization (IVF) technology would account for an unrivalled patient base, as compared to surrogacy and artificial insemination, on the back of the high success rate of the procedure. The introduction of preimplantation genetic diagnosis (PGD) technology helps medical professionals screen embryos for inherited diseases, which further improves the prospects of conceiving a healthy child.  Conditions such as PCOD/PCOS are found to worsen the reproductive performance of women, which leads to remote chances of conceivability, thereby encouraging women to undergo infertility treatment using assisted reproductive technology. Based on these relevant insights, authors of an exclusive Fact.MR study estimate a CAGR of around 6.3% for the expansion of the assisted reproductive technology market during the forecast period (2020-2025).

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Assisted Reproductive Technology Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Assisted Reproductive Technology market.

A subject matter expert at Fact.MR opines, “Currently, Europe, North America, Latin America, and a handful of countries in the Asia Pacific and the Middle East & Africa have regulations protecting the legal rights of the homosexual populace. However, homosexually-close relationships are progressively gaining acceptance in other countries too, which is indicative of the high demand for assisted reproductive technology in future.”

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=4393

Assisted Reproductive Technology Demand Analysis by Category

Procedure
  • Frozen Donor
  • Frozen Non-donor
  • Fresh Donor
  • Fresh Non-donor
  • Embryo Banking
Technology
  • In-vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Others
End User
  • Fertility Clinics
  • Hospitals
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa


Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4393

Key Highlights of Assisted Reproductive Technology Market Study

  • High costs associated with quality IVF and IUI procedures are gradually propelling a shift of patients from assisted reproductive technology towards naturopathic solutions and alternative therapies to treat infertility, which is posing as a threat to developmental efforts of market players.
  • Increasing number of dual working households with a career-intensive approach, in turn, continues to increase reproductive complexity, which is taken into account by major corporates. Efforts have been made by major companies, such as Google LLC, towards creating a conducive environment for female employees by offering facilities to store their eggs, thereby stimulating growth of the assisted reproductive technology market.
  • Initiatives taken by numerous public and private institutions such as ASPIRE are projected to raise awareness and increase the adoption of assisted reproductive technology in Asia Pacific. Public awareness campaigns are also being witnessed in the U.S. by central authorities such as the Society for Assisted Reproductive Technology and National Infertility Association, which is reflecting on the growing patient base for infertility treatment.
  • Cost benefits of artificial reproductive techniques in developing countries of Asia Pacific are attracting reproductive care seekers from across the world. The study finds that, a complete package of surrogacy costs merely one-third of that in the U.K., which is strengthening the position of Asia Pacific as a key surrogacy destination.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/4393

Cost-effectiveness of Alternative Medicines to Remain Pertinent Threat for Players

Numerous threats and challenges with varying influence are encountered by players in the assisted reproductive technology market, including threats of cost-effective alternative therapies and choice of child adoption. Though entry barriers in the assisted reproductive technology are high, on the back of huge CAPEX and OPEX requirements, intense development activities undertaken by existing players are influential enough to turn the landscape fragmented. For instance, a key player—Nidacon International AB—focuses on product innovation in the sperm diagnostic segment, and, in turn, extends efforts towards upgrading its existing product lines. Collaborations and alliances among leading players are also projected to foster improvements in fertility techniques, thereby leading to advancements in assisted reproductive technology.

Find More Valuable Insights on Assisted Reproductive Technology Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global assisted reproductive technology market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the assisted reproductive technology market on the basis of technology (in-vitro fertilization, surrogacy, artificial insemination, and others), procedure (frozen donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking), and end user (hospitals, fertility clinics, and others), across five major regions in the assisted reproductive technology market.

For More Insights 

https://www.biospace.com/article/legalization-and-strict-regularization-of-medical-cannabis-is-pivotal-for-improved-uptake-of-cannabis-analyzer-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Recombinant Protein Colony Stimulating Market Is Estimated to Account for Nearly US$ 460 Mn Revenues by 2022-end

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Recombinant Protein Market Over the Forecast Period 2017-2022

The Fact.MR study on the recombinant protein market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Product Type (Immune Checkpoint Regulators, Chemokines ), End Users ( Biopharmaceutical Companies, Contract Research Organizations ). The report also highlights the scope of recombinant protein over the assessment period

A new report published by Fact.MR estimates the global sales of recombinant protein to witness expansion at a moderate CAGR during the forecast period 2017 to 2022. Revenues from the global recombinant protein market will reach nearly US$ 460 Mn by 2022-end.

Through genetic engineering, and cell engineering, recombinant protein are produced from creature body. The recombinant protein technology now stands at the edge of biotechnology production. Becoming the new standard, this technology is witnessing a gradual shift from bulk production procedure towards post-production techniques, which in turn promises an enhanced delivery and stability. The highly effective recombinant proteins play an integral part in treating specific diseases, such as hemophilia. However, blood coagulation factor is excluded, as it possesses an extremely limited source.

A large number of recombinant protein drugs utilized are human proteins. This is mainly to compensate functional proteins in vivo defects, and for increasing the functions of proteins in a body. These factors provide recombinant proteins with substantially higher safety as compared to small molecules, further leading towards higher approval rates.

For More Insights Into The Market, Request a Sample of this Report 

https://www.factmr.com/connectus/sample?flag=S&rep_id=186

The clinical trial periods for recombinant proteins are comparatively shorter than small molecule drugs, which further aids in enhancing patient protection, and renders pharmaceutical companies with a relatively longer exclusive sales time. Factors such as these are driving the development, and demand for recombinant proteins. Recombinant proteins target diseases such as cardiovascular diseases, endocrine diseases, viral diseases, and cancer.

In addition, the global recombinant protein market has a larger extension space, with few approval drugs available without any alternative products in therapeutic areas. These factors might influence growth of the market over the forecast period. However, factors such as technical barriers, financial barriers have made recombinant protein technology expensive. Moreover, replication of recombinant proteins incurs many challenges, as compared to replication of small molecule chemicals. These factors may impede growth of the market in the near future.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=186

Recombinant Protein Demand Analysis by Category

Product Type

  • Immune Checkpoint Regulators
  • Chemokines
  • Growth Factors
  • Cytokines
  • Colony Stimulating Factors
  • Hormones
  • Enzymes & Inhibitors

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Food & Beverage Companies
  • Diagnostic Centers

Application

  • Drug Discovery & Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic TestingBasic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/186

Key Recombinant Protein Survey Highlights and Projections

  1. Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.
  2. Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.
  3. North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.
  4. Europe will continue to be the second largest market for recombinant proteins over the forecast period.
  5. The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.
  6. Academic & research institutes will remain the most lucrative end-users in the global recombinant proteins market, accounting for more than one-third revenue share of the market throughout the forecast period.
  7. Biopharmaceutical companies will continue to be the fastest expanding end-users of recombinant proteins in the global market.
  8. Although growth factors are estimated to remain the largest product segment, sales of chemokines will register the fastest expansion through 2022.

For More Insights

https://www.biospace.com/article/how-demand-for-renovascular-hypertension-treatment-growth-spurred-by-increasing-prevalence-of-kidney-disorders-opines-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Sanctions For Arthritis Research Funding Are Contributing In Demand Of Bilateral Osteoarthritis Treatment Market

A new report compiled by Fact.MR offers valuable insights pertaining to the growth prospects of the global bilateral osteoarthritis treatment market Sales during the forecast period, 2018-2028. Crucial information encapsulated in the research report offers perspectives on the overall impact of the technological advancements on the growth of the global market.

the report presents a full understanding of the major dynamics of the bilateral osteoarthritis treatment Market such as on-going market trends, opportunities, growth drivers, and barriers. The report inspects the micro and macro-economic factors that are anticipated to foster the growth of the bilateral osteoarthritis treatment Market.

Introduction

Osteoarthritis is one of the most common types of arthritis that affects a large group of population worldwide. Knees are one of the largest bone structures in the body, which is continually exposed to wear and damage that causes pain and chronic conditions such as osteoarthritis, which results in the development of bilateral osteoarthritis.

Bilateral osteoarthritis is one of the prime causes of disability in aged people, coupled with decreasing the quality of life. The treatment of bilateral osteoarthritis mainly consists of the utilisation of analgesics for reliving pain that is majorly caused by the inflammation of the knees.

To get in-depth insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2895

The latest market research report analyzes Bilateral Osteoarthritis Treatment Market demand by Different segments. Providing business leaders with insights On Bilateral Osteoarthritis Treatment And how they can increase their market share.

The report also offers key trends of Bilateral Osteoarthritis Treatment market and an in-depth analysis of how the projected growth factors will shape the Bilateral Osteoarthritis Treatment market dynamics in the coming years of the forecast period.

The Market insights of Bilateral Osteoarthritis Treatment will improve the revenue impact of businesses in various industries by:

  • Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Bilateral Osteoarthritis Treatment Market
  • Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Bilateral Osteoarthritis Treatment market and offers solutions
  • Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
  • Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
  • Helping leading companies make strategy recalibrations ahead of their competitors and peers
  • Offers insights into promising synergies for top players aiming to retain their leadership position in the market & supply side analysis of Bilateral Osteoarthritis Treatment market .

The latest industry analysis and survey on Bilateral Osteoarthritis Treatment provides sales outlook in 20+ countries, across key categories. Insights and outlook on Bilateral Osteoarthritis Treatment market drivers, trends, and influencing factors are also included in the study.

Bilateral Osteoarthritis Treatment Market: Segmentation

The global bilateral osteoarthritis treatment market can be segmented on the basis of treatment type, route of administration, distribution channel and geography.

Based on treatment type, the global bilateral osteoarthritis treatment market is segmented as:

  • Analgesics
    • Acetaminophen
    • Duloxetine
    • Others
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Aspirin
    • Ibuprofen
    • Naproxen
    • Diclofenac
  • Corticosteroids
  • Hyaluronic Acid

Based on the route of administration, the global bilateral osteoarthritis treatment market is segmented as:

  • Oral
  • Injectable

Based on the distribution channel, the global bilateral osteoarthritis treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce

This report gives you access to decisive data such as:

  • Demand of Bilateral Osteoarthritis Treatment Market & Growth drivers
  • Factors limiting Bilateral Osteoarthritis Treatment market growth
  • Current key trends of Bilateral Osteoarthritis Treatment Market
  • Market Size of Bilateral Osteoarthritis Treatment and Bilateral Osteoarthritis Treatment Sales projections for the coming years

Enquiry Before Buying – https://www.factmr.com/connectus/sample?flag=EB&rep_id=2895

Bilateral Osteoarthritis Treatment Market: Regional Outlook

Based on regions, the global bilateral osteoarthritis treatment market is segmented into Latin America, North America, Europe, Asia-Pacific excluding Japan (APEJ), CIS & Russia, the Middle East & Africa (MEA) and Japan.

Among these, North America is estimated to account for the largest revenue share in the global bilateral osteoarthritis treatment market owing to the local presence of key manufacturers and increase in the usage of corticosteroid-based bilateral osteoarthritis treatments in the region.

The Europe bilateral osteoarthritis treatment market is projected to be the second most lucrative region in the bilateral osteoarthritis treatment market over the forecast period.

The Asia Pacific excluding Japan bilateral osteoarthritis treatment market is estimated to grow at a high CAGR owing to the increasing incidence of arthritis and increased focus on effective drug manufacturing.

Hence, the Asia Pacific excluding Japan bilateral osteoarthritis treatment market and the Latin America bilateral osteoarthritis treatment market are expected to follow the Europe bilateral osteoarthritis treatment market throughout the forecast period.

Key Question answered in the Survey of Bilateral Osteoarthritis Treatment market Report By Fact.MR

  • Bilateral Osteoarthritis Treatment Company & brand share analysis: Company and brand share analysis on Bilateral Osteoarthritis Treatment Market reveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
  • Bilateral Osteoarthritis Treatment Market Historical volume analysis: The industry analysis provides data & insights on historical volume sales of Bilateral Osteoarthritis Treatment .
  • Bilateral Osteoarthritis Treatment Category & segment level analysis: Fact.MR’s Bilateral Osteoarthritis Treatment market sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify sales potential and set sales targets at local, country, and regional level.
  • Bilateral Osteoarthritis Treatment market Consumption by demographics: The market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
  • Post COVID consumer spending on Bilateral Osteoarthritis Treatment market: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
  • Manufacturing trend analysis: Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments
  • Bilateral Osteoarthritis Treatment market Merger and acquisition activity: MR’s analysis also includes merger & acquisition activity analysis. Bilateral Osteoarthritis Treatment market manufacturers and stakeholders will not only know the recent M&As but also understand its impact on competitive landscape and market share
  • Bilateral Osteoarthritis Treatment Market demand by country: The report forecasts Bilateral Osteoarthritis Treatment demand by country, giving business leaders the insights to know fast-growing, stable, and mature markets

Moreover, it also gives meaningful as well as actionable insights on the competitive analysis of Bilateral Osteoarthritis Treatment Market that are developing the current market scenario and which will be lucrative for the future demand of Bilateral Osteoarthritis Treatment Market.

Crucial insights in Bilateral Osteoarthritis Treatment market research report:

  • Underlying macro- and microeconomic factors impacting the Sales of Bilateral Osteoarthritis Treatment market.
  • Basic overview of the Bilateral Osteoarthritis Treatment, including market definition, classification, and applications.
  • Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend and supply side analysis of Bilateral Osteoarthritis Treatment across various industries.
  • Important regions and countries offering lucrative opportunities to market stakeholders.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2895

Leading Companies Profiled in the Bilateral Osteoarthritis Treatment Market are:

To provide decision-makers with credible insights on their competitive landscape, the Bilateral Osteoarthritis Treatment Market industry research report includes detailed competitive landscape analysis.

SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels.

Bilateral Osteoarthritis Treatment Market: Key Players

The global bilateral osteoarthritis treatment market is characterised by the presence of a large number of domestic manufacturers. Some of the key players in the global bilateral osteoarthritis treatment market are Johnson & Johnson Services, Inc.; Novartis AG; GlaxoSmithKline plc.; Abbott Laboratories and Zimmer Biomet Holdings, Inc.

Bilateral Osteoarthritis Treatment Market: Drivers

Advancements in research on bilateral osteoarthritis treatment, such as the development of low-dose corticosteroids and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), coupled with sanctions for arthritis research funding, are expected to be among the prime factors contributing to the growth of the bilateral osteoarthritis treatment market over the study period.

According the data from United Nations, nearly 12%-15% of adults aged 60 years and above are likely to suffer from normal to higher degrees of bilateral osteoarthritis, which is resulting in the higher prevalence of bilateral osteoarthritis, and this is boosting the demand for bilateral osteoarthritis treatment.

Although corticosteroids contribute to a limited share in the bilateral osteoarthritis treatment market, the higher efficacy of corticosteroids in the treatment of bilateral osteoarthritis is estimated to offer new growth opportunities for the bilateral osteoarthritis treatment market.

More Related Reports By Fact.MR On Healthcare Domain :

Adsorption Apheresis Devices Market  – Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2026

Vials Leak Testing Market – Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Increase Prevalence Rate Of Cancer Is Major Driver For Breast Biopsy Localization Market Demand

The Global  breast biopsy localization wire Market is all set to gain substantial demand opportunities from various end-use industries, according to a new report from Factor. This report on the global breast biopsy localization wire market Sales offers a complete overview of various key elements impacting positively or negatively on the overall growth of the market for breast biopsy localization wire.

Detailed information on consumptions and demand ratio of diverse products/services linked to the growth dynamics of the  breast biopsy localization wire market is covered in this report. This aside, the report presents reliable data on revenues and volumes of all key geographical regions during the forecast period 2018 to 2028.

Breast Biopsy Localization Wire : Market Insights

Accuracy in the localizing tumors mass or abnormality in the breast and creating a guiding line for the surgical procedure by breast biopsy localization wire has become the first choice of surgeons.

Major players in the breast biopsy localization wire market are involved into developing novel products of various length and width specifically designed to achieve great perfections while performing a biopsy on patient.

Lately developed high grade material used in productions of those breast biopsy localization wire where strength and greater and unbendable. These recent developments in breast biopsy localization wire have offered edge to the biopsy technique.

To get in-depth insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2881

The latest market research report analyzes Breast Biopsy Localization Wire Market demand by Different segments. Providing business leaders with insights On Breast Biopsy Localization Wire And how they can increase their market share.

The report also offers key trends of Breast Biopsy Localization Wire market and an in-depth analysis of how the projected growth factors will shape the Breast Biopsy Localization Wire market dynamics in the coming years of the forecast period.

The Market insights of Breast Biopsy Localization Wire will improve the revenue impact of businesses in various industries by:

  • Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Breast Biopsy Localization Wire Market
  • Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Breast Biopsy Localization Wire market and offers solutions
  • Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
  • Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
  • Helping leading companies make strategy recalibrations ahead of their competitors and peers
  • Offers insights into promising synergies for top players aiming to retain their leadership position in the market & supply side analysis of Breast Biopsy Localization Wire market .

The latest industry analysis and survey on Breast Biopsy Localization Wire provides sales outlook in 20+ countries, across key categories. Insights and outlook on Breast Biopsy Localization Wire market drivers, trends, and influencing factors are also included in the study.

The breast biopsy localization wire are in the market from last four decades, no any major changes have happened in the breast biopsy localization wire as it was the breakthrough technology offering less tissue disruption and can be performed prior to surgery. Ultra high end material is used in the breast biopsy localization wire for complying with the surgical needs.

The wire is mostly covered with the Ultrasound encasement at the tip of the breast biopsy localization wire to provide precision while operating. The continues technological changes in the breast biopsy localization wire will offer lucrative growth opportunities for the global breast biopsy localization wire market in the forthcoming years.

Global Breast Biopsy Localization Wire Market: Segmentation

Global Breast Biopsy Localization Wire is segmented by product type and end user:

  • Segmentation by Product Type
    • Single Burb
    • Double Burb
    • Others
  • Segmentation by End User
    • Hospitals Inpatients
    • Ambulatory Surgical Center
    • Others

This report gives you access to decisive data such as:

  • Demand of Breast Biopsy Localization Wire Market & Growth drivers
  • Factors limiting Breast Biopsy Localization Wire market growth
  • Current key trends of Breast Biopsy Localization Wire Market
  • Market Size of Breast Biopsy Localization Wire and Breast Biopsy Localization Wire Sales projections for the coming years

Enquiry Before Buying –  https://www.factmr.com/connectus/sample?flag=EB&rep_id=2881

Global Breast Biopsy Localization Wire Market: Region-wise Outlook

On the basis of geography, Global Breast Biopsy Localization Wire Market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

North America is expected to hold largest shares in the Breast Biopsy Localization Wire Market primarily due to presence of large number of hospitals and high quality healthcare infrastructure for clinical research and strict regulatory bodies.

Europe is expected to show second highest share in Breast biopsy localization wire market due to high prevalence of breast cancer and good healthcare expenditure as Belgium has the highest number of breast cancer cases in the world .

Germany has the highest healthcare expenditure. South America has the third largest incidence of breast cancer and is expected to hold average share in Breast Biopsy Localization Wire market.

Key Question answered in the Survey of Breast Biopsy Localization Wire market Report By Fact.MR

  • Breast Biopsy Localization Wire Company & brand share analysis: Company and brand share analysis on Breast Biopsy Localization Wire Market reveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
  • Breast Biopsy Localization Wire Market Historical volume analysis: The industry analysis provides data & insights on historical volume sales of Breast Biopsy Localization Wire .
  • Breast Biopsy Localization Wire Category & segment level analysis: Fact.MR’s Breast Biopsy Localization Wire market sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify sales potential and set sales targets at local, country, and regional level.
  • Breast Biopsy Localization Wire market Consumption by demographics: The market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
  • Post COVID consumer spending on Breast Biopsy Localization Wire market: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
  • Manufacturing trend analysis: Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments
  • Breast Biopsy Localization Wire market Merger and acquisition activity: MR’s analysis also includes merger & acquisition activity analysis. Breast Biopsy Localization Wire market manufacturers and stakeholders will not only know the recent M&As but also understand its impact on competitive landscape and market share
  • Breast Biopsy Localization Wire Market demand by country: The report forecasts Breast Biopsy Localization Wire demand by country, giving business leaders the insights to know fast-growing, stable, and mature markets

Moreover, it also gives meaningful as well as actionable insights on the competitive analysis of Breast Biopsy Localization Wire Market that are developing the current market scenario and which will be lucrative for the future demand of Breast Biopsy Localization Wire Market.

Crucial insights in Breast Biopsy Localization Wire market research report:

  • Underlying macro- and microeconomic factors impacting the Sales of Breast Biopsy Localization Wire market.
  • Basic overview of the Breast Biopsy Localization Wire, including market definition, classification, and applications.
  • Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend and supply side analysis of Breast Biopsy Localization Wire across various industries.
  • Important regions and countries offering lucrative opportunities to market stakeholders.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2881

Leading Companies Profiled in the Breast Biopsy Localization Wire Market are:

To provide decision-makers with credible insights on their competitive landscape, the Breast Biopsy Localization Wire Market industry research report includes detailed competitive landscape analysis.

SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels.

Breast Biopsy Localization Wire Market: Key Players

Some of the key players present in Global Breast Biopsy Localization wire Market are McKesson, SOMATEX Medical Technologies GmbH, Argon Medical Devices, Cook Medical, Medline and others.

Global Breast Biopsy Localization Wire Market: Snapsshot

Based on product type , Single Burp breast biopsy localization wire register the highest revenue share due to high adoption in the market on the account of better results and suitability for the lump size .

Rising prevalence of breast cancer and growing application of breast biopsy localization wire in removal of lump that cannot be felt, removal of small abnormal area that are hard for surgeons to find,

removal of tissue samples containing more than one abnormalities is one of the major factor driving the demand of breast biopsy localization wire for early management of patients, thereby global breast biopsy localization wire market over the globe.

However, the product manufacturers of breast biopsy localization wire for above breast disease management applications coupled with rising demand for these services is further expected to drive the revenue generation in global breast biopsy localization wire market.

More Related Reports By Fact.MR On Healthcare Domain :

Bone-Cutting Technologies Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Laryngeal Papillomatosis Treatment Market – Forecast, Trend Analysis & Competition Tracking – Global Market insights 2018 to 2028

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com